CHAIN’s Clostridium Assisted Drug Delivery (CADD) platform is an engineered strain of Clostridium bacteria that functions as a delivery vehicle for therapeutics. Engineered strains are manufactured in the form of spores and taken as tablets. The spores tolerate stomach acid and acid they germinate the colon the cells proliferate and release a bioactive molecule. CHAIN has other products in development aimed at treating infection, inflammation and metabolic disorders.
CHAIN’s treatment for Ulcerative Colitis and Crohn’s Disease has been completed pre-clnical testing. Scaling up the manufacturing of the Clostridial spore-based medicines following good manufacturing practice (GMP) will be aided by Porton Biopharma and Scitech. Other products in development focus on treating infection, inflammation and metabolic disorders.
Dr. Edward M. Green
Mr. Basil Omar
Founder, Chief Commercial Officer
Mr. Robert James Rickman
Chairman of Management Board
Documentaries, videos and podcasts